Ocrevus (ocrelizumab) - Roche
Pearls & Oy-sters: Diagnosis of Pediatric Tumefactive Multiple Sclerosis With MRI Biomarkers. (PubMed, Neurology) - Oct 2, 2026 - "The patient was treated with IV steroids followed by oral steroids and then started on ocrelizumab. This case demonstrates how recognition of CVS is critical, because early and accurate diagnosis enables timely treatment without unnecessary interventions." 
Biomarker • Journal • CNS Disorders • Multiple Sclerosis • Oncology • Pain • Pediatrics
http://www.ncbi.nlm.nih.gov/pubmed/42821841
 
Anne M Wagner; Aye Thant; Claudia Gambrah-Lyles; Kelsey Mackenzie Barter; Matthew Brier; Monye Pitt; Soe S Mar; Vishnuvardhan Thotakura
 
Oct 2, 2026
 
Prev Next